[HTML][HTML] PLK1, a potential target for cancer therapy

Z Liu, Q Sun, X Wang - Translational oncology, 2017 - Elsevier
Abstract Polo-like kinase 1 (PLK1) plays an important role in the initiation, maintenance, and
completion of mitosis. Dysfunction of PLK1 may promote cancerous transformation and drive …

[HTML][HTML] The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors

XTR Moore, L Gheghiani, Z Fu - Cells, 2023 - mdpi.com
Polo-like kinase 1 (PLK1) is a serine/threonine kinase with more than 600 phosphorylation
substrates through which it regulates many biological processes, including mitosis …

[HTML][HTML] PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia

K Shah, A Nasimian, M Ahmed, L Al Ashiri… - Blood Cancer …, 2023 - nature.com
The deregulation of BCL2 family proteins plays a crucial role in leukemia development.
Therefore, pharmacological inhibition of this family of proteins is becoming a prevalent …

[HTML][HTML] Boolean model of growth signaling, cell cycle and apoptosis predicts the molecular mechanism of aberrant cell cycle progression driven by hyperactive PI3K

H Sizek, A Hamel, D Deritei, S Campbell… - PLoS computational …, 2019 - journals.plos.org
The PI3K/AKT signaling pathway plays a role in most cellular functions linked to cancer
progression, including cell growth, proliferation, cell survival, tissue invasion and …

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

C Schmidl, GI Vladimer, AF Rendeiro… - Nature chemical …, 2019 - nature.com
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib has substantially improved therapeutic
options for chronic lymphocytic leukemia (CLL). Although ibrutinib is not curative, it has a …

[HTML][HTML] NF-kB as a key player in regulation of cellular radiation responses and identification of radiation countermeasures

V Singh, D Gupta, R Arora - Discoveries, 2015 - ncbi.nlm.nih.gov
Nuclear factor (NF)-κB is a transcription factor that plays significant role in immunity, cellular
survival and inhibition of apoptosis, through the induction of genetic networks. Depending …

Comprehensive analysis of PLKs expression and prognosis in breast cancer

W Jiawei, B Xiajun, S Tian, G Xuzheng, Z Zhenwang - Cancer Genetics, 2022 - Elsevier
Objective A thorough examination of PLKs in breast cancer, including their expression and
prognosis. Methods With the help of the Oncomine database, the transcript levels of PLKs in …

CARM1 contributes to skeletal muscle wasting by mediating FoxO3 activity and promoting myofiber autophagy

Y Liu, J Li, Y Shang, Y Guo, Z Li - Experimental cell research, 2019 - Elsevier
Coactivator-associated arginine methyltransferase 1 (CARM1) is involved in a variety of
biological processes in different cell types and disease conditions, including myogenesis …

[HTML][HTML] Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime

C Zhang, H Xu, X Sui, L Chen, B Chen, H Lv… - Molecular Therapy …, 2022 - cell.com
Natural killer/T cell lymphoma (NKTCL) is a highly aggressive subtype of non-Hodgkin
lymphoma. Gemcitabine, oxaliplatin, and L-asparaginase (GELOX) is one of the first-line …

[HTML][HTML] Apoptosis regulation by the tyrosine-protein kinase CSK

A Fortner, A Chera, A Tanca, O Bucur - Frontiers in Cell and …, 2022 - frontiersin.org
C-terminal Src kinase (CSK) is a cytosolic tyrosine-protein kinase with an important role in
regulating critical cellular decisions, such as cellular apoptosis, survival, proliferation …